<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

ETP-ALL May Be Linked To Acute Myeloid Leukemia

January 27, 2012

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012